logo
logo

Alex Therapeutics Raises €3.5M In Oversubscribed Financing Round From Top Tier Vc Investors To Advance Expansion In Europe And The Us.

Apr 06, 2022•over 3 years ago

Amount Raised

€3.5 Million

Round Type

seed

Stockholm

Description

Stockholm-based Digital Therapeutics (DTx) company Alex Therapeutics today announces it has secured a €3.5M funding round, led by European life science venture fund Hadean Ventures and joined by Scale Capital and Bonit Capital.

Company Information

Company

Alex Therapeutics

Location

Stockholm, Stockholm County, Sweden

About

Alex Therapeutics is a digital therapeutics (DTx) company based in Stockholm which designs and develops Software-as-a-Medical-Devices (SaMDs). With the proven "Alex DTx Platform", expertise in artificial intelligence and evidence-based psychology, Alex Therapeutics is uniquely positioned to deliver cutting-edge and reliable DTx products. The company has treated tens of thousands of patients, has experience with clinical validation, and overwhelmingly positive patient testimonials. For more information, visit www.alextherapeutics.com or follow us on LinkedIn.